Positive news for people experiencing menopause has been announced this week.
NICE has approved the use of the first non-hormonal treatment specifically developed to manage hot flushes associated with the menopause.
Hot flushes and night sweats can hugely affect daily life by disrupting sleep, concentration, relationships, and the ability to work.
HRT is the first line treatment for hot flushes but for some women HRT is not an option – often due to a history of cancer.
Until now that has meant relying on medications that were not designed for menopausal symptoms and which often provide limited relief.
Fezolinetant offers a new treatment option for this group.
